<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-126331</identifier>
<setSpec>1699-695X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Pyogenic Granuloma with Bone Loss in a patient taking Contraceptives</dc:title>
<dc:description xml:lang="en">Pyogenic Granuloma is one of the reactive inflammatory oral diseases associated with contraceptive intake. The clinical features are not pathognomonic therefore its diagnosis must be made with histological support. Its incidence is higher in women who are in the second and third decade of life. Although its aetiology remains controversial there is clear evidence that it is a reaction to the presence of local irritants such as biofilms together with systemic conditions such as hormonal changes (AU)</dc:description>
<dc:creator>Díaz Caballero, Antonio</dc:creator>
<dc:creator>González Martínez, Farith</dc:creator>
<dc:creator>López Arrieta, Zulieth</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El granuloma telangiectásico se incluye dentro de las patologías reactivas inflamatorias orales asociadas a efectos secundarios de la ingesta de anovulatorios. Sus características clínicas no son patognomónicas, por lo que su diagnosis se debe realizar con apoyo en estudios histológicos. En cuanto a su incidencia, es mayor en mujeres que se encuentran en la segunda y tercera décadas de la vida. Aunque el factor etiológico aún es discutido, existe evidencia clara de que es una reacción que conjuga la presencia de factores irritantes locales, como la biopelícula, y condiciones sistémicas, como lo son las alteraciones hormonales (AU)</dc:description>
<dc:source>Rev. clín. med. fam;4(1): 79-81, feb. 2011. ilus</dc:source>
<dc:identifier>ibc-126331</dc:identifier>
<dc:title xml:lang="es">Granuloma Telangiectásico y Pérdida Ósea asociado a tratamiento Anovulatorio</dc:title>
<dc:subject>^d31431^s22012</dc:subject>
<dc:subject>^d6024^s22012</dc:subject>
<dc:subject>^d7144^s22012</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d3297^s22073</dc:subject>
<dc:subject>^d4977^s22012</dc:subject>
<dc:subject>^d10705^s22016</dc:subject>
<dc:subject>^d10701^s22053</dc:subject>
<dc:subject>^d4977^s22016</dc:subject>
<dc:subject>^d31431^s22009</dc:subject>
<dc:subject>^d10705^s22032</dc:subject>
<dc:subject>^d10701^s29166</dc:subject>
<dc:subject>^d31431^s22016</dc:subject>
<dc:subject>^d6250^s22009</dc:subject>
<dc:subject>^d10705^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>201102</dc:date>
</metadata>
</record>
</ibecs-document>
